Cresp Darbepoetin Alfa 100 Mcg

Cresp Darbepoetin Alfa 100 Mcg injection is an advanced erythropoiesis-stimulating agent (ESA) used to treat anemia, particularly in patients with chronic kidney disease (CKD) and those undergoing chemotherapy. It contains Darbepoetin alfa, a synthetic protein that stimulates the bone marrow to produce red blood cells. This helps increase hemoglobin levels and reduces the need for blood transfusions.

Cresp Injection is widely used in clinical settings to manage anemia caused by reduced erythropoietin production. It works similarly to natural erythropoietin but has a longer half-life, allowing for less frequent dosing and improved patient convenience. Improving oxygen-carrying capacity in the blood helps reduce fatigue, weakness, and shortness of breath associated with anemia.

The injection is administered subcutaneously or intravenously under medical supervision. It is essential to monitor hemoglobin levels regularly during treatment to ensure optimal dosing and avoid complications. Cresp Darbepoetin Alfa is a trusted and effective therapy for anemia management, improving quality of life and overall patient outcomes when used as prescribed.

Product Features

• Contains Darbepoetin alfa – long-acting ESA
• Stimulates red blood cell production effectively
• Reduces the need for frequent blood transfusions
• Longer duration allows less frequent dosing
• Suitable for CKD and chemotherapy-induced anemia

How It Helps

• Increases hemoglobin and red blood cell levels
• Reduces fatigue and weakness caused by anemia
• Improves oxygen delivery throughout the body
• Enhances the overall quality of life in patients